nodes	percent_of_prediction	percent_of_DWPC	metapath
Lidocaine—SLC22A5—Dactinomycin—ocular cancer	0.716	0.798	CbGbCtD
Lidocaine—ABCB1—Dactinomycin—ocular cancer	0.182	0.202	CbGbCtD
Lidocaine—EGFR—Disease—RBL1—ocular cancer	0.000148	0.00144	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR in Cancer—CDKN1B—ocular cancer	0.000148	0.00144	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways in Glioblastoma—AKT1—ocular cancer	0.000148	0.00144	CbGpPWpGaD
Lidocaine—EGFR—DAP12 signaling—CDKN1A—ocular cancer	0.000148	0.00144	CbGpPWpGaD
Lidocaine—EGFR—Signaling by PDGF—CDKN1B—ocular cancer	0.000148	0.00144	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—PSPH—ocular cancer	0.000147	0.00144	CbGpPWpGaD
Lidocaine—ABCB1—HIF-1-alpha transcription factor network—EP300—ocular cancer	0.000147	0.00143	CbGpPWpGaD
Lidocaine—EGFR—NGF signalling via TRKA from the plasma membrane—MDM2—ocular cancer	0.000146	0.00143	CbGpPWpGaD
Lidocaine—EGFR—Downstream signaling events of B Cell Receptor (BCR)—CDKN1A—ocular cancer	0.000146	0.00142	CbGpPWpGaD
Lidocaine—SCN9A—Developmental Biology—EP300—ocular cancer	0.000143	0.00139	CbGpPWpGaD
Lidocaine—EGFR—Constitutive PI3K/AKT Signaling in Cancer—AKT1—ocular cancer	0.000143	0.00139	CbGpPWpGaD
Lidocaine—EGFR—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.000142	0.00138	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.000141	0.00138	CbGpPWpGaD
Lidocaine—EGFR—B Cell Activation—CDKN1B—ocular cancer	0.00014	0.00136	CbGpPWpGaD
Lidocaine—EGFR—DAP12 interactions—CDKN1A—ocular cancer	0.000139	0.00136	CbGpPWpGaD
Lidocaine—EGFR—Fc epsilon receptor (FCERI) signaling—CDKN1A—ocular cancer	0.000139	0.00136	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR in disease—CDKN1A—ocular cancer	0.000139	0.00136	CbGpPWpGaD
Lidocaine—EGFR—Androgen receptor signaling pathway—AKT1—ocular cancer	0.000139	0.00135	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR—CDKN1A—ocular cancer	0.000138	0.00134	CbGpPWpGaD
Lidocaine—EGFR—ErbB1 downstream signaling—HRAS—ocular cancer	0.000138	0.00134	CbGpPWpGaD
Lidocaine—SCN9A—Axon guidance—HRAS—ocular cancer	0.000137	0.00134	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR in Cancer—CDKN1A—ocular cancer	0.000137	0.00133	CbGpPWpGaD
Lidocaine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—ocular cancer	0.000137	0.00133	CbGpPWpGaD
Lidocaine—SCN3A—Developmental Biology—EP300—ocular cancer	0.000137	0.00133	CbGpPWpGaD
Lidocaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—ocular cancer	0.000136	0.00133	CbGpPWpGaD
Lidocaine—EGFR—Signaling by PDGF—CDKN1A—ocular cancer	0.000136	0.00133	CbGpPWpGaD
Lidocaine—EGFR—Focal Adhesion—CCND1—ocular cancer	0.000136	0.00133	CbGpPWpGaD
Lidocaine—EGFR—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.000135	0.00132	CbGpPWpGaD
Lidocaine—EGFR—NGF signalling via TRKA from the plasma membrane—CDKN1B—ocular cancer	0.000134	0.0013	CbGpPWpGaD
Lidocaine—SCN2A—Developmental Biology—EP300—ocular cancer	0.000131	0.00128	CbGpPWpGaD
Lidocaine—SCN4A—Developmental Biology—EP300—ocular cancer	0.000131	0.00128	CbGpPWpGaD
Lidocaine—EGFR—Spinal Cord Injury—TP53—ocular cancer	0.000131	0.00128	CbGpPWpGaD
Lidocaine—EGFR—Integrated Breast Cancer Pathway—MYC—ocular cancer	0.000131	0.00128	CbGpPWpGaD
Lidocaine—SCN3A—Axon guidance—HRAS—ocular cancer	0.000131	0.00128	CbGpPWpGaD
Lidocaine—EGFR—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.000131	0.00128	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.00013	0.00127	CbGpPWpGaD
Lidocaine—EGFR—B Cell Activation—CDKN1A—ocular cancer	0.000129	0.00126	CbGpPWpGaD
Lidocaine—EGFR—PI-3K cascade—AKT1—ocular cancer	0.000128	0.00125	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—PSPH—ocular cancer	0.000128	0.00124	CbGpPWpGaD
Lidocaine—SCN10A—Developmental Biology—EP300—ocular cancer	0.000127	0.00123	CbGpPWpGaD
Lidocaine—SCN4A—Axon guidance—HRAS—ocular cancer	0.000126	0.00123	CbGpPWpGaD
Lidocaine—SCN2A—Axon guidance—HRAS—ocular cancer	0.000126	0.00123	CbGpPWpGaD
Lidocaine—EGFR—PI3K/AKT activation—AKT1—ocular cancer	0.000125	0.00122	CbGpPWpGaD
Lidocaine—EGFR—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000125	0.00121	CbGpPWpGaD
Lidocaine—EGFR—GAB1 signalosome—AKT1—ocular cancer	0.000124	0.00121	CbGpPWpGaD
Lidocaine—SCN9A—Developmental Biology—TGFB1—ocular cancer	0.000124	0.00121	CbGpPWpGaD
Lidocaine—EGFR—NGF signalling via TRKA from the plasma membrane—CDKN1A—ocular cancer	0.000123	0.0012	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—SAG—ocular cancer	0.000122	0.00119	CbGpPWpGaD
Lidocaine—EGFR—Role of LAT2/NTAL/LAB on calcium mobilization—AKT1—ocular cancer	0.000122	0.00118	CbGpPWpGaD
Lidocaine—EGFR—ErbB1 downstream signaling—AKT1—ocular cancer	0.000122	0.00118	CbGpPWpGaD
Lidocaine—SCN10A—Axon guidance—HRAS—ocular cancer	0.000121	0.00118	CbGpPWpGaD
Lidocaine—EGFR—MAPK Signaling Pathway—MYC—ocular cancer	0.00012	0.00117	CbGpPWpGaD
Lidocaine—EGFR—MAPK Signaling Pathway—TGFB1—ocular cancer	0.00012	0.00117	CbGpPWpGaD
Lidocaine—EGFR—Disease—TFDP1—ocular cancer	0.00012	0.00116	CbGpPWpGaD
Lidocaine—SCN3A—Developmental Biology—TGFB1—ocular cancer	0.000119	0.00116	CbGpPWpGaD
Lidocaine—EGFR—Direct p53 effectors—TP53—ocular cancer	0.000114	0.00111	CbGpPWpGaD
Lidocaine—SCN2A—Developmental Biology—TGFB1—ocular cancer	0.000114	0.00111	CbGpPWpGaD
Lidocaine—SCN4A—Developmental Biology—TGFB1—ocular cancer	0.000114	0.00111	CbGpPWpGaD
Lidocaine—CYP2A6—NRF2 pathway—TGFB1—ocular cancer	0.000114	0.00111	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—MDM2—ocular cancer	0.000113	0.0011	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.000112	0.00109	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—PSPH—ocular cancer	0.000111	0.00108	CbGpPWpGaD
Lidocaine—ABCB1—Allograft Rejection—TGFB1—ocular cancer	0.000111	0.00108	CbGpPWpGaD
Lidocaine—SCN10A—Developmental Biology—TGFB1—ocular cancer	0.00011	0.00107	CbGpPWpGaD
Lidocaine—EGFR—Signaling by SCF-KIT—HRAS—ocular cancer	0.000109	0.00106	CbGpPWpGaD
Lidocaine—EGFR—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.000109	0.00106	CbGpPWpGaD
Lidocaine—EGFR—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.000108	0.00106	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—E2F5—ocular cancer	0.000108	0.00105	CbGpPWpGaD
Lidocaine—EGFR—Integrated Breast Cancer Pathway—TP53—ocular cancer	0.000108	0.00105	CbGpPWpGaD
Lidocaine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—ocular cancer	0.000107	0.00105	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—E2F4—ocular cancer	0.000106	0.00103	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.000106	0.00103	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PSPH—ocular cancer	0.000105	0.00102	CbGpPWpGaD
Lidocaine—EGFR—Downstream signaling of activated FGFR—HRAS—ocular cancer	0.000104	0.00101	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PSPH—ocular cancer	0.000104	0.00101	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—RBL1—ocular cancer	0.000104	0.00101	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—CDKN1B—ocular cancer	0.000103	0.001	CbGpPWpGaD
Lidocaine—EGFR—Signaling by ERBB4—HRAS—ocular cancer	0.000102	0.000998	CbGpPWpGaD
Lidocaine—EGFR—MAPK Signaling Pathway—TP53—ocular cancer	9.88e-05	0.000963	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—GNA11—ocular cancer	9.82e-05	0.000957	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—CDK4—ocular cancer	9.81e-05	0.000955	CbGpPWpGaD
Lidocaine—EGFR—Downstream signal transduction—HRAS—ocular cancer	9.78e-05	0.000953	CbGpPWpGaD
Lidocaine—SCN9A—Developmental Biology—HRAS—ocular cancer	9.78e-05	0.000953	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR—HRAS—ocular cancer	9.73e-05	0.000948	CbGpPWpGaD
Lidocaine—EGFR—EGF/EGFR Signaling Pathway—HRAS—ocular cancer	9.73e-05	0.000948	CbGpPWpGaD
Lidocaine—EGFR—Signaling by ERBB2—HRAS—ocular cancer	9.68e-05	0.000944	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—GNA11—ocular cancer	9.66e-05	0.000941	CbGpPWpGaD
Lidocaine—EGFR—DAP12 signaling—HRAS—ocular cancer	9.64e-05	0.000939	CbGpPWpGaD
Lidocaine—EGFR—Signaling by SCF-KIT—AKT1—ocular cancer	9.6e-05	0.000936	CbGpPWpGaD
Lidocaine—EGFR—Downstream signaling events of B Cell Receptor (BCR)—HRAS—ocular cancer	9.5e-05	0.000926	CbGpPWpGaD
Lidocaine—EGFR—Disease—MAML2—ocular cancer	9.5e-05	0.000925	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—CDKN1A—ocular cancer	9.48e-05	0.000924	CbGpPWpGaD
Lidocaine—SCN3A—Developmental Biology—HRAS—ocular cancer	9.35e-05	0.000911	CbGpPWpGaD
Lidocaine—EGFR—Downstream signaling of activated FGFR—AKT1—ocular cancer	9.19e-05	0.000895	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—GNAQ—ocular cancer	9.13e-05	0.00089	CbGpPWpGaD
Lidocaine—EGFR—Integrated Breast Cancer Pathway—AKT1—ocular cancer	9.09e-05	0.000886	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR in disease—HRAS—ocular cancer	9.07e-05	0.000883	CbGpPWpGaD
Lidocaine—EGFR—DAP12 interactions—HRAS—ocular cancer	9.07e-05	0.000883	CbGpPWpGaD
Lidocaine—EGFR—Fc epsilon receptor (FCERI) signaling—HRAS—ocular cancer	9.07e-05	0.000883	CbGpPWpGaD
Lidocaine—EGFR—Signaling by ERBB4—AKT1—ocular cancer	9.04e-05	0.000881	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—E2F3—ocular cancer	9e-05	0.000877	CbGpPWpGaD
Lidocaine—SCN2A—Developmental Biology—HRAS—ocular cancer	8.99e-05	0.000876	CbGpPWpGaD
Lidocaine—SCN4A—Developmental Biology—HRAS—ocular cancer	8.99e-05	0.000876	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR—HRAS—ocular cancer	8.99e-05	0.000876	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—GNAQ—ocular cancer	8.98e-05	0.000875	CbGpPWpGaD
Lidocaine—EGFR—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	8.92e-05	0.000869	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR in Cancer—HRAS—ocular cancer	8.91e-05	0.000868	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—EP300—ocular cancer	8.9e-05	0.000867	CbGpPWpGaD
Lidocaine—ABCB1—HIF-1-alpha transcription factor network—AKT1—ocular cancer	8.9e-05	0.000867	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PSPH—ocular cancer	8.88e-05	0.000866	CbGpPWpGaD
Lidocaine—EGFR—Signaling by PDGF—HRAS—ocular cancer	8.87e-05	0.000864	CbGpPWpGaD
Lidocaine—SCN10A—Developmental Biology—HRAS—ocular cancer	8.67e-05	0.000844	CbGpPWpGaD
Lidocaine—EGFR—Downstream signal transduction—AKT1—ocular cancer	8.64e-05	0.000842	CbGpPWpGaD
Lidocaine—SCN9A—Developmental Biology—AKT1—ocular cancer	8.64e-05	0.000841	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR—AKT1—ocular cancer	8.59e-05	0.000837	CbGpPWpGaD
Lidocaine—EGFR—EGF/EGFR Signaling Pathway—AKT1—ocular cancer	8.59e-05	0.000837	CbGpPWpGaD
Lidocaine—EGFR—Focal Adhesion—HRAS—ocular cancer	8.57e-05	0.000835	CbGpPWpGaD
Lidocaine—EGFR—Signaling by ERBB2—AKT1—ocular cancer	8.55e-05	0.000833	CbGpPWpGaD
Lidocaine—SCN5A—Axon guidance—HRAS—ocular cancer	8.54e-05	0.000832	CbGpPWpGaD
Lidocaine—EGFR—DAP12 signaling—AKT1—ocular cancer	8.51e-05	0.000829	CbGpPWpGaD
Lidocaine—EGFR—B Cell Activation—HRAS—ocular cancer	8.39e-05	0.000818	CbGpPWpGaD
Lidocaine—EGFR—Downstream signaling events of B Cell Receptor (BCR)—AKT1—ocular cancer	8.39e-05	0.000817	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—TFDP1—ocular cancer	8.37e-05	0.000816	CbGpPWpGaD
Lidocaine—EGFR—MAPK Signaling Pathway—AKT1—ocular cancer	8.35e-05	0.000813	CbGpPWpGaD
Lidocaine—SCN3A—Developmental Biology—AKT1—ocular cancer	8.26e-05	0.000805	CbGpPWpGaD
Lidocaine—EGFR—NGF signalling via TRKA from the plasma membrane—HRAS—ocular cancer	8.03e-05	0.000782	CbGpPWpGaD
Lidocaine—EGFR—DAP12 interactions—AKT1—ocular cancer	8.01e-05	0.00078	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR in disease—AKT1—ocular cancer	8.01e-05	0.00078	CbGpPWpGaD
Lidocaine—EGFR—Fc epsilon receptor (FCERI) signaling—AKT1—ocular cancer	8.01e-05	0.00078	CbGpPWpGaD
Lidocaine—SCN2A—Developmental Biology—AKT1—ocular cancer	7.94e-05	0.000773	CbGpPWpGaD
Lidocaine—SCN4A—Developmental Biology—AKT1—ocular cancer	7.94e-05	0.000773	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR—AKT1—ocular cancer	7.93e-05	0.000773	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR in Cancer—AKT1—ocular cancer	7.86e-05	0.000766	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	7.85e-05	0.000765	CbGpPWpGaD
Lidocaine—EGFR—Signaling by PDGF—AKT1—ocular cancer	7.83e-05	0.000763	CbGpPWpGaD
Lidocaine—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—ocular cancer	7.76e-05	0.000756	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—TGFB1—ocular cancer	7.74e-05	0.000754	CbGpPWpGaD
Lidocaine—SCN10A—Developmental Biology—AKT1—ocular cancer	7.65e-05	0.000746	CbGpPWpGaD
Lidocaine—EGFR—Focal Adhesion—AKT1—ocular cancer	7.56e-05	0.000737	CbGpPWpGaD
Lidocaine—EGFR—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	7.53e-05	0.000734	CbGpPWpGaD
Lidocaine—EGFR—B Cell Activation—AKT1—ocular cancer	7.41e-05	0.000722	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	7.16e-05	0.000698	CbGpPWpGaD
Lidocaine—EGFR—NGF signalling via TRKA from the plasma membrane—AKT1—ocular cancer	7.09e-05	0.000691	CbGpPWpGaD
Lidocaine—EGFR—Disease—HDAC1—ocular cancer	6.94e-05	0.000677	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PSPH—ocular cancer	6.86e-05	0.000668	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	6.84e-05	0.000666	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—MAML2—ocular cancer	6.65e-05	0.000648	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	6.61e-05	0.000644	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—GNA11—ocular cancer	6.42e-05	0.000626	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—MDM2—ocular cancer	6.42e-05	0.000626	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	6.29e-05	0.000613	CbGpPWpGaD
Lidocaine—EGFR—Disease—CDKN2B—ocular cancer	6.22e-05	0.000606	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—HRAS—ocular cancer	6.18e-05	0.000602	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—MDM2—ocular cancer	6.16e-05	0.000601	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—HRAS—ocular cancer	6.09e-05	0.000594	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—GNAQ—ocular cancer	5.97e-05	0.000582	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—GNA11—ocular cancer	5.88e-05	0.000573	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—CDKN1B—ocular cancer	5.86e-05	0.000571	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—EP300—ocular cancer	5.83e-05	0.000568	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—GNA11—ocular cancer	5.8e-05	0.000565	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—CDKN1B—ocular cancer	5.63e-05	0.000548	CbGpPWpGaD
Lidocaine—EGFR—Axon guidance—HRAS—ocular cancer	5.59e-05	0.000545	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	5.48e-05	0.000534	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—GNAQ—ocular cancer	5.47e-05	0.000533	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	5.47e-05	0.000533	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—AKT1—ocular cancer	5.45e-05	0.000531	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—CDKN1A—ocular cancer	5.41e-05	0.000527	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—GNAQ—ocular cancer	5.39e-05	0.000526	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—AKT1—ocular cancer	5.38e-05	0.000524	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—CDKN1A—ocular cancer	5.19e-05	0.000506	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—EP300—ocular cancer	5.15e-05	0.000502	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—TGFB1—ocular cancer	5.07e-05	0.000494	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—HDAC1—ocular cancer	4.86e-05	0.000474	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—GNA11—ocular cancer	4.75e-05	0.000463	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—GNA11—ocular cancer	4.64e-05	0.000452	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	4.5e-05	0.000439	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—GNAQ—ocular cancer	4.41e-05	0.00043	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CDKN2B—ocular cancer	4.36e-05	0.000425	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—GNAQ—ocular cancer	4.31e-05	0.00042	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—GNA11—ocular cancer	4.02e-05	0.000392	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—E2F1—ocular cancer	4e-05	0.00039	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—HRAS—ocular cancer	3.99e-05	0.000389	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	3.8e-05	0.00037	CbGpPWpGaD
Lidocaine—EGFR—Immune System—MDM2—ocular cancer	3.74e-05	0.000364	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—GNAQ—ocular cancer	3.74e-05	0.000364	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—HRAS—ocular cancer	3.52e-05	0.000343	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—AKT1—ocular cancer	3.52e-05	0.000343	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—GNA11—ocular cancer	3.5e-05	0.000341	CbGpPWpGaD
Lidocaine—EGFR—Disease—MDM2—ocular cancer	3.45e-05	0.000336	CbGpPWpGaD
Lidocaine—EGFR—Immune System—CDKN1B—ocular cancer	3.41e-05	0.000333	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—HRAS—ocular cancer	3.38e-05	0.00033	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—GNA11—ocular cancer	3.3e-05	0.000322	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—GNA11—ocular cancer	3.27e-05	0.000319	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—GNAQ—ocular cancer	3.26e-05	0.000317	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—EP300—ocular cancer	3.23e-05	0.000314	CbGpPWpGaD
Lidocaine—EGFR—Disease—CDKN1B—ocular cancer	3.15e-05	0.000307	CbGpPWpGaD
Lidocaine—EGFR—Immune System—CDKN1A—ocular cancer	3.15e-05	0.000307	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—AKT1—ocular cancer	3.11e-05	0.000303	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—GNAQ—ocular cancer	3.07e-05	0.000299	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—GNAQ—ocular cancer	3.04e-05	0.000296	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—ocular cancer	3.02e-05	0.000294	CbGpPWpGaD
Lidocaine—EGFR—Immune System—EP300—ocular cancer	3e-05	0.000292	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—AKT1—ocular cancer	2.99e-05	0.000291	CbGpPWpGaD
Lidocaine—EGFR—Disease—CDKN1A—ocular cancer	2.91e-05	0.000283	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—GNA11—ocular cancer	2.8e-05	0.000272	CbGpPWpGaD
Lidocaine—EGFR—Disease—EP300—ocular cancer	2.77e-05	0.00027	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—GNAQ—ocular cancer	2.6e-05	0.000253	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—ocular cancer	2.45e-05	0.000239	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—MDM2—ocular cancer	2.42e-05	0.000236	CbGpPWpGaD
Lidocaine—EGFR—Disease—MYC—ocular cancer	2.41e-05	0.000235	CbGpPWpGaD
Lidocaine—EGFR—Disease—TGFB1—ocular cancer	2.41e-05	0.000234	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—HRAS—ocular cancer	2.25e-05	0.000219	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CDKN1B—ocular cancer	2.21e-05	0.000215	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—GNA11—ocular cancer	2.16e-05	0.00021	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—EP300—ocular cancer	2.15e-05	0.000209	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CCND1—ocular cancer	2.11e-05	0.000205	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—ocular cancer	2.1e-05	0.000204	CbGpPWpGaD
Lidocaine—EGFR—Immune System—HRAS—ocular cancer	2.05e-05	0.0002	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CDKN1A—ocular cancer	2.04e-05	0.000198	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—GNAQ—ocular cancer	2.01e-05	0.000195	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—AKT1—ocular cancer	1.98e-05	0.000193	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—EP300—ocular cancer	1.97e-05	0.000192	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—AKT1—ocular cancer	1.95e-05	0.00019	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—EP300—ocular cancer	1.94e-05	0.000189	CbGpPWpGaD
Lidocaine—EGFR—Disease—HRAS—ocular cancer	1.89e-05	0.000185	CbGpPWpGaD
Lidocaine—EGFR—Immune System—AKT1—ocular cancer	1.81e-05	0.000177	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—MYC—ocular cancer	1.69e-05	0.000165	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—TGFB1—ocular cancer	1.68e-05	0.000164	CbGpPWpGaD
Lidocaine—EGFR—Disease—AKT1—ocular cancer	1.67e-05	0.000163	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—EP300—ocular cancer	1.59e-05	0.000155	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—EP300—ocular cancer	1.55e-05	0.000151	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—TP53—ocular cancer	1.39e-05	0.000135	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—EP300—ocular cancer	1.34e-05	0.000131	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—HRAS—ocular cancer	1.33e-05	0.000129	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—AKT1—ocular cancer	1.3e-05	0.000126	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—AKT1—ocular cancer	1.19e-05	0.000116	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—AKT1—ocular cancer	1.17e-05	0.000114	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—EP300—ocular cancer	1.17e-05	0.000114	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—EP300—ocular cancer	1.1e-05	0.000107	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—EP300—ocular cancer	1.09e-05	0.000107	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—AKT1—ocular cancer	9.59e-06	9.34e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—AKT1—ocular cancer	9.37e-06	9.13e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—EP300—ocular cancer	9.34e-06	9.1e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—AKT1—ocular cancer	8.12e-06	7.91e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—EP300—ocular cancer	7.21e-06	7.02e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—AKT1—ocular cancer	7.07e-06	6.89e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—AKT1—ocular cancer	6.66e-06	6.49e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—AKT1—ocular cancer	6.61e-06	6.44e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—AKT1—ocular cancer	5.64e-06	5.5e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—AKT1—ocular cancer	4.36e-06	4.24e-05	CbGpPWpGaD
